This chapter summarizes the sex-and gender-specific diagnosis and treatment of
acute/unstable presentations and nacute/stable presentations of cardiovascular disease in …

Health-related quality of life (HRQOL) is an important clinical and research trial endpoint in
adult heart failure and has been shown to predict mortality and hospitalizations in adult heart …

Aims The study sought to investigate the association between admission systolic blood
pressure (SBP) and 1‐year clinical outcomes in patients hospitalized for heart failure (HF) …

Aims The addition of hydrochlorothiazide (HCTZ) to furosemide improved the diuretic
response in patients with acute heart failure (AHF) in the CLOROTIC trial. Our aim was to …

Objectives The aim of this study was to assess sex differences in the efficacy and safety of
baroreflex activation therapy (BAT) in the BeAT-HF (Baroreflex Activation Therapy for Heart …

Congestion is a primary driver of symptoms in patients with acute heart failure (AHF),
leading to emergency department visits and heart failure (HF) hospitalizations. Increased …

Background: Due to the lack of evidence and inconsistency of sex differences in Heart
failure (HF) in the Chinese population, this study aimed to compare sex differences in …

Background Studies focusing on sex differences in circulating proteins in patients with heart
failure with reduced ejection fraction (HFrEF) are scarce. Insight into sex-specific …

Objective We examined temporal heart failure (HF) prescription patterns in a large
representative sample of real-world patients in the UK, using electronic health records …

Chronic Chagas cardiomyopathy (CCC) is among Latin America's leading causes of heart
failure (HF). Trypanosoma cruzi causes Chagas disease, and the prognosis of HF resulting …